Combining TTF-1 with Napsin A reduces misinterpretation risks in most cases, since Napsin A positivity, which should be detectable in pulmonary adenocarcinomas, was absent in colorectal tumors. The gene discussed is NAPSA; the disease is colorectal neoplasm.